Related Experiment Video
Updated: Nov 8, 2025
06:59
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
161
Endovascular therapies for pulmonary embolism
Hervé Rousseau1, Costantino Del Giudice2, Olivier Sanchez3
1Service d'imagerie CHU Toulouse, Rangueil, France.
Heliyon
|April 23, 2021
Summary
New endovascular techniques offer options for managing pulmonary embolism (PE). This consensus defines their role based on risk stratification, guiding treatment for intermediate-risk patients to improve outcomes.
Area of Science:
- Cardiology
- Interventional Radiology
- Pulmonary Medicine
Background:
- Pulmonary embolism (PE) management varies by risk.
- Intermediate-risk PE patients face controversial treatment strategies.
- Aggressive treatment is needed for some intermediate-risk PE patients due to mortality risk.
Purpose of the Study:
- Define the role of new endovascular methods for PE management.
- Establish a multidisciplinary consensus on PE treatment.
- Guide the use of endovascular thrombectomy in PE.
Main Methods:
- Literature review on PE management.
- Multidisciplinary consensus development.
- Risk stratification of pulmonary embolism patients.
Main Results:
- High-risk PE: systemic thrombolysis or embolectomy recommended.
- Low-risk PE: anticoagulation alone is proposed.
- Intermediate-risk PE: treatment is controversial; endovascular approaches are considered.
Conclusions:
- Endovascular thrombectomy's place defined by PE risk stratification.
- Multidisciplinary teams are crucial for complex PE cases.
- Appropriate risk stratification guides the choice between thrombolysis, mechanical methods, or surgery.
Related Concept Videos
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
96
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
96
01:29Venous Thrombosis III: Interprofessional Care
91
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
91
01:27Pulmonary Embolism III: Nursing Management
113
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
113
01:29Pulmonary Embolism I: Introduction
226
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
226
01:27Peripheral Artery Disease III: Interprofessional Care
96
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
96
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
306
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
306